AstraZeneca (AZN) Tops Q1 EPS by 139c
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NASDAQ: AZN) reported Q1 EPS of $2.49, $1.39 better than the analyst estimate of $1.10. Revenue for the quarter came in at $13.59 billion versus the consensus estimate of $13.77 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Liveworld, Inc. (LVWD) Reports In-Line Q2 EPS
- Active options: NVDA TSLA SPCX MU AAPL INTC CRWV
- Trump: Leavitt Will Be Departing Her Role
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
